Healthcare | June 09, 2026
Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
The session created a platform for meaningful discussions on the challenges of the disease and the importance of timely intervention
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
